Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Single-arm Dose Escalation Study to Determine the Safety and Bioavailability of a Natural Compound Arctigenin in Healthy Men

NCT03703388 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03703388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03703388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Single-arm Dose Escalation Study to Determine the Safety and Bioavailability of a Natural Compound Arctigenin in Healthy Men
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2019
Completion date
July 15, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy